Top

Published in:

01-01-2011

Myocardial remodeling, an overview

Authors: Dennis V. Cokkinos, Costas Pantos

Published in: Heart Failure Reviews | Issue 1/2011

Excerpt

Myocardial remodeling (REM) is a deleterious process characterized by gradual cardiac enlargement, cardiac dysfunction and typical molecular changes. It is a universal phenomenon, being caused by many pathological conditions [1, 2]. …

Diez J, Ertl GA (2009) Translational approach to myocardial remodelling. Cardiovasc Res 81:409–411PubMedCrossRef

Hill JA, Olson EN (2008) Cardiac plasticity. N Engl J Med 358:1370–1380PubMedCrossRef

Savoye C, Equine O, Tricot O et al (2006) Left ventricular remodelling after anterior wall acute myocardial infarction in modern clinical practice (from the Remodelage Ventriculaire [REVE] study group. Am J Cardiol 98:1144–1149PubMedCrossRef

Papadopoulos CE, Karvounis HI, Giannakoulas G et al (2007) Predictors of left ventricular remodelling after reperfused acute myocardial infarction. Am J Cardiol 99:1024–1025PubMedCrossRef

Miura T, Miki T (2008) Limitation of myocardial infarct size in the clinical setting: current status and challenges in translating animal experiments into clinical therapy. Basic Res Cardiol 103:501–513PubMedCrossRef

Tribouilloy C, Grigioni G, Avierinos J-F et al (2009) Survival implications of left ventricular end-systolic diameter in mitral regurgitation due to flail leaflets: a long-term follow-up multicenter study. J Am Coll Cardiol 54:1961–1968PubMedCrossRef

Yeh ETH, Bickford Cl (2009) Cardiovascular complications of cancer therapy. J Am Coll 53:2231–2247CrossRef

Pfeffer JM, Pfeffer MA, Braunwald E (1985) Influence on chronic captopril theraphy on the infarcted left ventricle of the rat. Circ Res 57:84–95PubMed

Opie LH, Commerford RJ, Gersh BJ et al (2006) Controversies in ventricular remodeling. Lancet 367:356–367PubMedCrossRef

10.

Dorn GW II, Robbins J, Sugden PH (2003) Phenotyping hypertrophy: eschew obfuscation. Circ Res 92:171–1175CrossRef

11.

Burak M, Frangogiannis NG (2007) The role of TGF-β signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res 74:184–195CrossRef

12.

Frey N, Olson EN (2003) Cardiac hypertrophy: the good, the bad and the ugly. Annu Rev Physiol 65:45–79PubMedCrossRef

13.

Westenbrink BD, Ruifrok W-PT, Voors AA et al (2010) Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure. Cardiovasc Res 87:30–39PubMedCrossRef

14.

Swynghedaw B (2006) Phenotypic plasticity of adult myocardium. Molecular mechanisms. J Exp Biol 209:2320–2327CrossRef

15.

Rajabi M, Kassiotis C, Razeghi P, Taegtmeyer H (2007) Return to the fetal gene program protects the stressed heart: a strong hypothesis. Heart Fail Rev 12:331–343PubMedCrossRef

16.

Heusch G, Schulz R, Rahimtoola SH (2005) Myocardial hibernation-a delicate balance. Am J Physiol Heart Circ Physiol 288:H984–H999PubMedCrossRef

17.

Baker JE, Holman P, Gross GJ (1999) Preconditioning in immature rabbit hearts: role of Katp channels. Circulation 99:1249–1254PubMed

18.

Krenz M, Robbins J (2004) Impact of beta-myosin heavy chain expression on cardiac function during stress. J Am Coll Cardiol 44:2390–2397PubMedCrossRef

19.

Cleniewski-Bernard C, Mulder P, Henry JP et al (2008) Proteomic analysis of left ventricular remodeling in an experimental model of heart failure. J Proteome Res 7:5004–5016CrossRef

20.

Sarwar R, Copok SA (2009) Genomic analysis of left ventricular remodelling. Circulation 120:437–444PubMedCrossRef

21.

Tijsen AJ, Creemers EE, Moerland PD et al (2010) MiR423–5p as a circulating biomarker for heart failure: questions about MiR-423–5p. Circ Res 106:1035–1039PubMedCrossRef

22.

Matkovich SJ, Wang W, Tu Y et al (2010) MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overload adult hearts. Circ Res 106:166–175CrossRef

23.

De Boer RA, Voors AA, Muntendam P et al (2009) Galectin-3: a novel mediator of heart failure development progression. Eur J Heart Fail 11:811–817PubMedCrossRef

24.

Weir RAP, Miller AM, Murphy GEJ et al (2010) Soluble ST2 is marker for predicting post-MI recovery. J Am Coll Cardiol 55:243–250CrossRef

25.

Shyu KG, Lu MJ, Wang BM et al (2006) Myostatin expression in ventricular myocardium in rat model of volume-overload heart failure. Eur J Clin Invest 36:713–719PubMedCrossRef

26.

George I, Bish LT, Kamalakkannan G et al (2010) Myostatin activation in patients with advanced heart failure and after mechanical unloading. Eur J Heart Fail 12:420–422CrossRef

27.

Ishii H, Amano T, Matsubara T, Myrohara T et al (2008) Pharmacological intervention for prevention of left ventricular remodeling and improving prognosis in myocardial infarction. Circulation 118:2710–2718PubMedCrossRef

28.

Bolognese L, Nescovic AN, Parodi G et al (2002) Left ventricular remodeling after primary coronary angioplasty: patterns of left ventricular dilation and long-term prognostic implications. Circulation 106:2351–2357PubMedCrossRef

29.

Cokkinos DV (2004) Preconditioning—a paradigm of yin and yang. Hellenic J Cardiol 43:179–182

Title: Myocardial remodeling, an overview
Authors: Dennis V. Cokkinos
Costas Pantos
Publication date: 01-01-2011
Publisher: Springer US
Published in: Heart Failure Reviews / Issue 1/2011
Print ISSN: 1382-4147
Electronic ISSN: 1573-7322
DOI: https://doi.org/10.1007/s10741-010-9192-4

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Myocardial remodeling, an overview

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2011

New insights into the role of thyroid hormone in cardiac remodeling: time to reconsider?

NADPH oxidases and cardiac remodelling

Cellular and molecular pathways to myocardial necrosis and replacement fibrosis

TNFα in myocardial ischemia/reperfusion, remodeling and heart failure

STAT3 and cardiac remodeling

Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page